Corcept Therapeutics Inc SEC filings CORT

Corcept Therapeutics Inc has 1,001 filings in SEC EDGAR's recent list, going back to Mar 10, 2016. Its latest annual report, Form 10-K, was filed on Feb 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
DEF 14A Proxy statement Apr 17, 2026 Apr 17, 2026
DEF 14A Proxy statement Apr 25, 2025 Apr 25, 2025
DEFA14A Additional proxy material Apr 18, 2024 —
DEF 14A Proxy statement Apr 10, 2024 Apr 10, 2024
DEFA14A Additional proxy material May 8, 2023 —
DEF 14A Proxy statement Apr 14, 2023 —
PRE 14A Preliminary proxy statement Apr 4, 2023 —
DEF 14A Proxy statement Apr 25, 2022 Apr 25, 2022
DEF 14A Proxy statement Apr 22, 2021 Apr 22, 2021
DEF 14A Proxy statement Apr 27, 2020 Apr 27, 2020
DEF 14A Proxy statement Apr 24, 2019 Jun 18, 2019
DEF 14A Proxy statement Apr 24, 2018 May 29, 2018
DEF 14A Proxy statement Apr 21, 2017 May 24, 2017
DEF 14A Proxy statement Apr 22, 2016 May 19, 2016

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CORT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Redwood City, CA
SEC filer status
Large accelerated filer
SEC CIK
1088856

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.